MCC-555

Known as: MCC 555, RWJ-241947 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2012
02419982012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
MCC-555 is a novel PPARα/γ dual ligand of the thiazolidinedione class and was recently developed as an anti-diabetic drug with… (More)
Is this relevant?
2010
2010
Peroxisome proliferator-activated receptor gamma (PPARgamma) plays a central role in cell differentiation, metabolism and… (More)
Is this relevant?
2008
2008
A large body of studies has suggested that peroxisome proliferator-activated receptor gamma (PPARgamma) ligands, such as… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Apoptosis and/or differentiation induction caused by the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand is a… (More)
Is this relevant?
2005
2005
Thiazolidinediones (TZDs) are anti-diabetic agents that enhance insulin sensitivity through activating peroxisome proliferator… (More)
Is this relevant?
2004
2004
PURPOSE RWJ-241947 (MCC-555) is a novel peroxisome proliferator-activated receptor-gamma ligand of the thiazolidinedione class… (More)
Is this relevant?
1998
1998
Freshly isolated adult rat ventricular cardiomyocytes have been used to characterize the action profile of the new… (More)
Is this relevant?
1998
1998
1. Young (6-week-old) pre-diabetic Zucker Diabetic Fatty (ZDF) rats displaying impaired glucose tolerance (IGT), moderate… (More)
Is this relevant?
1998
1998
1. We examined the effect of chronic (21 days) oral treatment with the thiazolidinedione, MCC-555 ((+)-5-[[6-(2-fluorbenzyl)-oxy… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Thiazolidinediones (TZDs) constitute an exciting new class of antidiabetic compounds, which function as activating ligands for… (More)
Is this relevant?